From knowledge silos to integrated insights: building a cardiovascular medication knowledge graph for enhanced

Hongzhen Cui1, Xiaoyue Zhu1, Wei Zhang2,3

  • 1School of Computer and Communication Engineering, University of Science and Technology Beijing, Beijing, China.

Insights

This study constructs an Expert Knowledge Graph of Cardiovascular Medication Guidelines (EKG-CMG) to integrate fragmented knowledge, improving personalized cardiovascular disease treatment and reducing medication risks for better clinical decision-making.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Knowledge Engineering

Background:

  • Cardiovascular diseases present complex diagnostic and treatment challenges, increasing medication risks.
  • Existing cardiovascular medication knowledge is fragmented, hindering clinical decision support.
  • Personalized medicine demands integrated, visualized expert knowledge systems.

Purpose of the Study:

  • To construct a comprehensive Expert Knowledge Graph of Cardiovascular Medication Guidelines (EKG-CMG).
  • To integrate unstructured and semi-structured cardiovascular medication knowledge (CMK).
  • To create a visually integrated cardiovascular expert knowledge system for clinical support.

Main Methods:

  • Utilized expert consensus and guidelines to structure knowledge.
  • Employed BERT and knowledge extraction for drug attribute relationships.
  • Stored and visualized knowledge in Neo4j graph database for retrieval and reasoning.

Main Results:

  • Constructed an ontology with 12 medication types and detailed attributes.
  • Developed EKG-CMG with 22,475 medication entities and 3,304 relationships.
  • Demonstrated EKG-CMG's capability for knowledge retrieval in precision medication scenarios.

Conclusions:

  • EKG-CMG systematically organizes CMK, bridging knowledge gaps between diseases and drugs.
  • Visualization technology facilitates semantic retrieval and complex knowledge relationship exploration.
  • The system supports enhanced medication semantic retrieval and reasoning for clinical application.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
461
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
706
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
284
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
509